High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection.

MLA

Carvalho, Gerusa B., et al. “High-through Identification of T Cell-Specific Phage-Exposed Mimotopes Using PBMCs from Tegumentary Leishmaniasis Patients and Their Use as Vaccine Candidates against Leishmania Amazonensis Infection.” Parasitology, vol. 146, no. 3, Mar. 2019, pp. 322–32. EBSCOhost, https://doi.org/10.1017/S0031182018001403.

APA

Carvalho, G. B., Costa, L. E., Lage, D. P., Ramos, F. F., Santos, T. T. O., Ribeiro, P. A. F., Dias, D. S., Salles, B. C. S., Lima, M. P., Carvalho, L. M., Dias, A. C. S., Alves, P. T., Franklin, M. L., Silva, R. A. M., Duarte, M. C., Menezes-Souza, D., Roatt, B. M., Chávez-Fumagalli, M. A., Goulart, L. R., & Teixeira, A. L. (2019). High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection. Parasitology, 146(3), 322–332. https://doi.org/10.1017/S0031182018001403

Chicago

Carvalho, Gerusa B., Lourena E. Costa, Daniela P. Lage, Fernanda F. Ramos, Thaís T. O. Santos, Patrícia A. F. Ribeiro, Daniel S. Dias, et al. 2019. “High-through Identification of T Cell-Specific Phage-Exposed Mimotopes Using PBMCs from Tegumentary Leishmaniasis Patients and Their Use as Vaccine Candidates against Leishmania Amazonensis Infection.” Parasitology 146 (3): 322–32. doi:10.1017/S0031182018001403.